Characteristic

n (%)

Sex

Male

Female

35 (55.8)

28 (44.4)

Age (years), mean ± SD

63.38

±11.107

Comorbidities (n = 63)

Hypertension

Coronary artery disease

Cerebrovascular disease

Chronic obstructive pulmonary disease

46 (73)

11 (17.5)

3 (4.8)

2 (3.2)

Body mass index, kg/m² (n = 58) (WHO general population [16] )

<18.5 (Underweight)

18.5 - 24.9 (normal weight)

>25.0 - 29.9 (pre-obesity)

2 (3.2)

37 (58.7)

19 (30.2)

Medications

Calcium carbonate (CaC03)

Erythrocyte-stimulating agent

Iron

Dipeptidyl peptidase-4 inhibitor inhibitors

Calcium channel blockers

Angiotensin receptor blockers

Antiplatelet

Angiotensin-converting enzyme inhibitor

Nitrates

Insulin

Alpha 2 agonists

Statins

Sevelamer carbonate

57 (90.5)

54 (85.7)

53 (84.1)

37 (58.7)

34 (54.0)

32 (50.8)

21 (33.3)

20 (31.7)

16 (25.4)

12 (19.0)

9 (14.3)

6 (9.5)

3 (4.8)